The point-of-care diagnostics devices and equipment market size has grown rapidly in recent years. It will grow from $64.11 billion in 2025 to $71.62 billion in 2026 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to growing burden of chronic diseases, increasing demand for rapid clinical decision-making, expansion of outpatient healthcare services, rising adoption of portable diagnostic devices, growth of preventive healthcare practices.
The point-of-care diagnostics devices and equipment market size is expected to see rapid growth in the next few years. It will grow to $118.72 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to increasing demand for home healthcare diagnostics, rising adoption of digital health ecosystems, expansion of infectious disease screening programs, growing integration of ai-based diagnostic support, increasing focus on remote patient monitoring. Major trends in the forecast period include increasing adoption of rapid diagnostic testing devices, rising demand for decentralized healthcare diagnostics, growing integration of connected point-of-care platforms, expansion of home-based testing solutions, enhanced focus on user-friendly device design.
The growing adoption of mobile health technologies is anticipated to drive the expansion of the point-of-care diagnostics devices market in the coming years. Mobile health refers to the use of mobile devices such as smartphones and tablets, along with other wireless technologies including wearable devices, to deliver healthcare services, share information, and monitor health-related data. Point-of-care diagnostics (POC) devices play an important role in mobile health (mHealth) by enabling fast and convenient testing and data collection at or near the patient’s location. These devices are designed to deliver immediate results for a wide range of medical tests and are often integrated with mobile applications or connected to smartphones for data management and transmission. For example, in February 2025, according to PharmiWeb, approximately 23% of healthcare encounters are expected to take place virtually in 2025. Therefore, the increasing adoption of mobile health technologies is contributing to the growth of the point-of-care diagnostics devices market.
Major companies in the point-of-care diagnostic devices and equipment market are developing innovative products such as Cippoint to improve access to healthcare and reduce diagnosis time. Cippoint is a state-of-the-art point-of-care testing device for multiple health conditions, offering a wide range of testing parameters, including cardiac markers, diabetes, infectious diseases, fertility, thyroid function, inflammation, metabolic markers, and coagulation markers. For instance, in January 2023, Cipla Limited launched Cippoint, an immunofluorescence-based quantitative analyzer that provides rapid test results, enabling healthcare professionals to make clinical decisions more quickly and efficiently in various settings.
In December 2023, Roche, a Switzerland-based provider of in vitro diagnostics, pharmaceuticals, and healthcare solutions, acquired select point-of-care (POC) technology assets from LumiraDx for $295 million. Through this acquisition, Roche seeks to incorporate a versatile, multi-assay point-of-care testing platform into its diagnostics portfolio to expand decentralized testing capabilities in primary care and low-resource settings. LumiraDx is a UK-based company that provides point-of-care diagnostics.
Major companies operating in the point-of-care diagnostics devices and equipment market are Abbott Laboratories, F. Hoffmann-La Roche AG, Siemens Healthineers, Danaher, Beckman Coulter, Becton Dickinson and Company, Qiagen N.V., Johnson & Johnson, Alere, BioMerieux, Chembio Diagnostic Systems, Quidel Corporation, EKF Diagnostics, Trinity Biotech Plc, OraSure Technologies, Sysmex Corporation, Radiometer Medical ApS, Response Biomedical Corporation, Bio-Rad Laboratories, Illumina, Thermo Fisher Scientific Inc., LabCorp, Luminex Corporation, LifeScan, Nova, Sekisui Diagnostics, Hemocue AB, Akers Biosciences,
North America was the largest region in the point-of-care diagnostic devices and equipment market in 2025. Asia-Pacific was the second-largest region in the global point-of-care diagnostics devices and equipment market. The regions covered in the point-of-care diagnostics devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the point-of-care diagnostics devices and equipment market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are impacting the point-of-care diagnostics devices and equipment market by increasing costs of imported biosensors, test strips, cartridges, microelectronics, and optical components used across diagnostic platforms. Hospitals, diagnostic centers, and home healthcare providers in North America and Europe are most affected due to reliance on imported consumables and devices, while Asia-Pacific faces higher manufacturing and export costs. These tariffs are increasing per-test costs and slowing device upgrades. However, they are also driving domestic production of consumables, localized device assembly, and innovation in cost-efficient point-of-care diagnostic solutions.
The point-of-care diagnostics devices and equipment market research report is one of a series of new reports that provides point-of-care diagnostics devices and equipment market statistics, including point-of-care diagnostics devices and equipment industry global market size, regional shares, competitors with a point-of-care diagnostics devices and equipment market share, detailed point-of-care diagnostics devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care diagnostics devices and equipment industry. This point-of-care diagnostics devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Point-of-care diagnostics devices are essential tools designed to assist healthcare professionals in conducting immediate medical diagnostic tests at or in close proximity to the patient's location. These devices are instrumental in providing rapid and on-the-spot information regarding various diseases or health conditions. They find application in a wide range of diagnostic tests, such as measuring glucose and cholesterol levels, electrolyte and enzyme analysis, detecting drugs of abuse, and diagnosing infectious diseases and pregnancy.
The primary categories of point-of-care diagnostic devices and equipment include infectious disease testing kits, cardiometabolic monitoring kits, cholesterol testing kits, pregnancy and fertility test kits, tumor/cancer markers, urinalysis testing kits, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, and various other diagnostic tools. Pregnancy and fertility test kits, for example, are point-of-care diagnostic devices that enable individuals to assess pregnancy and fertility status without the need to visit a healthcare provider. These devices are available in various prescription modes, including prescription-based testing devices and over-the-counter (OTC) testing devices. They serve a diverse range of end-users, including professional diagnostic centers, hospitals and critical care facilities, outpatient healthcare settings, ambulatory care facilities, research laboratories, and homes, contributing to more accessible and immediate healthcare information.
The point-of-care diagnostics market consists of sales of instruments such as pregnancy and fertility testing kits, cholesterol test strips, drug abuse testing kits, and others that are used in point-of-care diagnostics. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The point-of-care diagnostics devices and equipment market size is expected to see rapid growth in the next few years. It will grow to $118.72 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to increasing demand for home healthcare diagnostics, rising adoption of digital health ecosystems, expansion of infectious disease screening programs, growing integration of ai-based diagnostic support, increasing focus on remote patient monitoring. Major trends in the forecast period include increasing adoption of rapid diagnostic testing devices, rising demand for decentralized healthcare diagnostics, growing integration of connected point-of-care platforms, expansion of home-based testing solutions, enhanced focus on user-friendly device design.
The growing adoption of mobile health technologies is anticipated to drive the expansion of the point-of-care diagnostics devices market in the coming years. Mobile health refers to the use of mobile devices such as smartphones and tablets, along with other wireless technologies including wearable devices, to deliver healthcare services, share information, and monitor health-related data. Point-of-care diagnostics (POC) devices play an important role in mobile health (mHealth) by enabling fast and convenient testing and data collection at or near the patient’s location. These devices are designed to deliver immediate results for a wide range of medical tests and are often integrated with mobile applications or connected to smartphones for data management and transmission. For example, in February 2025, according to PharmiWeb, approximately 23% of healthcare encounters are expected to take place virtually in 2025. Therefore, the increasing adoption of mobile health technologies is contributing to the growth of the point-of-care diagnostics devices market.
Major companies in the point-of-care diagnostic devices and equipment market are developing innovative products such as Cippoint to improve access to healthcare and reduce diagnosis time. Cippoint is a state-of-the-art point-of-care testing device for multiple health conditions, offering a wide range of testing parameters, including cardiac markers, diabetes, infectious diseases, fertility, thyroid function, inflammation, metabolic markers, and coagulation markers. For instance, in January 2023, Cipla Limited launched Cippoint, an immunofluorescence-based quantitative analyzer that provides rapid test results, enabling healthcare professionals to make clinical decisions more quickly and efficiently in various settings.
In December 2023, Roche, a Switzerland-based provider of in vitro diagnostics, pharmaceuticals, and healthcare solutions, acquired select point-of-care (POC) technology assets from LumiraDx for $295 million. Through this acquisition, Roche seeks to incorporate a versatile, multi-assay point-of-care testing platform into its diagnostics portfolio to expand decentralized testing capabilities in primary care and low-resource settings. LumiraDx is a UK-based company that provides point-of-care diagnostics.
Major companies operating in the point-of-care diagnostics devices and equipment market are Abbott Laboratories, F. Hoffmann-La Roche AG, Siemens Healthineers, Danaher, Beckman Coulter, Becton Dickinson and Company, Qiagen N.V., Johnson & Johnson, Alere, BioMerieux, Chembio Diagnostic Systems, Quidel Corporation, EKF Diagnostics, Trinity Biotech Plc, OraSure Technologies, Sysmex Corporation, Radiometer Medical ApS, Response Biomedical Corporation, Bio-Rad Laboratories, Illumina, Thermo Fisher Scientific Inc., LabCorp, Luminex Corporation, LifeScan, Nova, Sekisui Diagnostics, Hemocue AB, Akers Biosciences,
North America was the largest region in the point-of-care diagnostic devices and equipment market in 2025. Asia-Pacific was the second-largest region in the global point-of-care diagnostics devices and equipment market. The regions covered in the point-of-care diagnostics devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the point-of-care diagnostics devices and equipment market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are impacting the point-of-care diagnostics devices and equipment market by increasing costs of imported biosensors, test strips, cartridges, microelectronics, and optical components used across diagnostic platforms. Hospitals, diagnostic centers, and home healthcare providers in North America and Europe are most affected due to reliance on imported consumables and devices, while Asia-Pacific faces higher manufacturing and export costs. These tariffs are increasing per-test costs and slowing device upgrades. However, they are also driving domestic production of consumables, localized device assembly, and innovation in cost-efficient point-of-care diagnostic solutions.
The point-of-care diagnostics devices and equipment market research report is one of a series of new reports that provides point-of-care diagnostics devices and equipment market statistics, including point-of-care diagnostics devices and equipment industry global market size, regional shares, competitors with a point-of-care diagnostics devices and equipment market share, detailed point-of-care diagnostics devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care diagnostics devices and equipment industry. This point-of-care diagnostics devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Point-of-care diagnostics devices are essential tools designed to assist healthcare professionals in conducting immediate medical diagnostic tests at or in close proximity to the patient's location. These devices are instrumental in providing rapid and on-the-spot information regarding various diseases or health conditions. They find application in a wide range of diagnostic tests, such as measuring glucose and cholesterol levels, electrolyte and enzyme analysis, detecting drugs of abuse, and diagnosing infectious diseases and pregnancy.
The primary categories of point-of-care diagnostic devices and equipment include infectious disease testing kits, cardiometabolic monitoring kits, cholesterol testing kits, pregnancy and fertility test kits, tumor/cancer markers, urinalysis testing kits, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, and various other diagnostic tools. Pregnancy and fertility test kits, for example, are point-of-care diagnostic devices that enable individuals to assess pregnancy and fertility status without the need to visit a healthcare provider. These devices are available in various prescription modes, including prescription-based testing devices and over-the-counter (OTC) testing devices. They serve a diverse range of end-users, including professional diagnostic centers, hospitals and critical care facilities, outpatient healthcare settings, ambulatory care facilities, research laboratories, and homes, contributing to more accessible and immediate healthcare information.
The point-of-care diagnostics market consists of sales of instruments such as pregnancy and fertility testing kits, cholesterol test strips, drug abuse testing kits, and others that are used in point-of-care diagnostics. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Point-of-Care Diagnostics Devices and Equipment Market Characteristics
3. Point-of-Care Diagnostics Devices and Equipment Market Supply Chain Analysis
4. Global Point-of-Care Diagnostics Devices and Equipment Market Trends and Strategies
5. Point-of-Care Diagnostics Devices and Equipment Market Analysis of End Use Industries
7. Global Point-of-Care Diagnostics Devices and Equipment Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Point-of-Care Diagnostics Devices and Equipment Total Addressable Market (TAM) Analysis for the Market
9. Point-of-Care Diagnostics Devices and Equipment Market Segmentation
10. Point-of-Care Diagnostics Devices and Equipment Market Regional and Country Analysis
11. Asia-Pacific Point-of-Care Diagnostics Devices and Equipment Market
12. China Point-of-Care Diagnostics Devices and Equipment Market
13. India Point-of-Care Diagnostics Devices and Equipment Market
14. Japan Point-of-Care Diagnostics Devices and Equipment Market
15. Australia Point-of-Care Diagnostics Devices and Equipment Market
16. Indonesia Point-of-Care Diagnostics Devices and Equipment Market
17. South Korea Point-of-Care Diagnostics Devices and Equipment Market
18. Bangladesh Point-of-Care Diagnostics Devices and Equipment Market
19. Thailand Point-of-Care Diagnostics Devices and Equipment Market
20. Vietnam Point-of-Care Diagnostics Devices and Equipment Market
21. Malaysia Point-of-Care Diagnostics Devices and Equipment Market
22. Singapore Point-of-Care Diagnostics Devices and Equipment Market
23. Philippines Point-of-Care Diagnostics Devices and Equipment Market
24. Hong Kong Point-of-Care Diagnostics Devices and Equipment Market
25. New Zealand Point-of-Care Diagnostics Devices and Equipment Market
26. Taiwan Point-of-Care Diagnostics Devices and Equipment Market
27. South East Asia Point-of-Care Diagnostics Devices and Equipment Market
28. Western Europe Point-of-Care Diagnostics Devices and Equipment Market
29. UK Point-of-Care Diagnostics Devices and Equipment Market
30. Germany Point-of-Care Diagnostics Devices and Equipment Market
31. France Point-of-Care Diagnostics Devices and Equipment Market
32. Italy Point-of-Care Diagnostics Devices and Equipment Market
33. Spain Point-of-Care Diagnostics Devices and Equipment Market
34. Austria Point-of-Care Diagnostics Devices and Equipment Market
35. Belgium Point-of-Care Diagnostics Devices and Equipment Market
36. Denmark Point-of-Care Diagnostics Devices and Equipment Market
37. Finland Point-of-Care Diagnostics Devices and Equipment Market
38. Ireland Point-of-Care Diagnostics Devices and Equipment Market
39. Netherlands Point-of-Care Diagnostics Devices and Equipment Market
40. Norway Point-of-Care Diagnostics Devices and Equipment Market
41. Portugal Point-of-Care Diagnostics Devices and Equipment Market
42. Sweden Point-of-Care Diagnostics Devices and Equipment Market
42. Switzerland Point-of-Care Diagnostics Devices and Equipment Market
43. Eastern Europe Point-of-Care Diagnostics Devices and Equipment Market
44. Russia Point-of-Care Diagnostics Devices and Equipment Market
45. Czech Republic Point-of-Care Diagnostics Devices and Equipment Market
46. Poland Point-of-Care Diagnostics Devices and Equipment Market
47. Romania Point-of-Care Diagnostics Devices and Equipment Market
48. Ukraine Point-of-Care Diagnostics Devices and Equipment Market
49. North America Point-of-Care Diagnostics Devices and Equipment Market
50. USA Point-of-Care Diagnostics Devices and Equipment Market
51. Canada Point-of-Care Diagnostics Devices and Equipment Market
52. Mexico Point-of-Care Diagnostics Devices and Equipment Market
53. South America Point-of-Care Diagnostics Devices and Equipment Market
54. Brazil Point-of-Care Diagnostics Devices and Equipment Market
55. Chile Point-of-Care Diagnostics Devices and Equipment Market
56. Argentina Point-of-Care Diagnostics Devices and Equipment Market
57. Colombia Point-of-Care Diagnostics Devices and Equipment Market
58. Peru Point-of-Care Diagnostics Devices and Equipment Market
59. Middle East Point-of-Care Diagnostics Devices and Equipment Market
60. Saudi Arabia Point-of-Care Diagnostics Devices and Equipment Market
61. Israel Point-of-Care Diagnostics Devices and Equipment Market
62. Iran Point-of-Care Diagnostics Devices and Equipment Market
63. Turkey Point-of-Care Diagnostics Devices and Equipment Market
64. United Arab Emirates Point-of-Care Diagnostics Devices and Equipment Market
65. Africa Point-of-Care Diagnostics Devices and Equipment Market
66. Egypt Point-of-Care Diagnostics Devices and Equipment Market
67. Nigeria Point-of-Care Diagnostics Devices and Equipment Market
68. South Africa Point-of-Care Diagnostics Devices and Equipment Market
70. Point-of-Care Diagnostics Devices and Equipment Market Competitive Landscape and Company Profiles
71. Point-of-Care Diagnostics Devices and Equipment Market Other Major and Innovative Companies
74. Point-of-Care Diagnostics Devices and Equipment Market High Potential Countries, Segments and Strategies
75. Appendix
Executive Summary
Point-of-Care Diagnostics Devices And Equipment Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses point-of-care diagnostics devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for point-of-care diagnostics devices and equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The point-of-care diagnostics devices and equipment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Infectious disease testing kits; Cardio metabolic monitoring kits; Cholesterol testing kits; Pregnancy and fertility tests kits; Tumor Or cancer markers; Urinalysis testing kits; Hematology testing kits; Drugs of abuse testing kits; Fecal occult testing kits; Other Types2) By Prescription Mode: Prescription-based Testing Devices; Over-The-Counter (OTC) Testing Devices
3) By End User: Professional diagnostic centers; Hospitals/critical care centers; Outpatient healthcare Setting; Ambulatory care settings; Research laboratories; Home
Subsegments:
1) By Infectious Disease Testing Kits: HIV Testing Kits; Hepatitis Testing Kits; Malaria Testing Kits; Influenza Testing Kits; COVID-19 Testing Kits; Other Infectious Disease Testing Kits2) By Cardio Metabolic Monitoring Kits: Blood Glucose Testing Kits; Blood Pressure Monitoring Kits; Lipid Testing Kits; Other Cardio Metabolic Monitoring Kits
3) By Cholesterol Testing Kits: Total Cholesterol Testing Kits; HDL Cholesterol Testing Kits; LDL Cholesterol Testing Kits; Triglyceride Testing Kits
4) By Pregnancy and Fertility Test Kits: Pregnancy Test Kits; Ovulation Test Kits; Fertility Monitoring Kits
5) By Tumor Or Cancer Markers: Prostate-Specific Antigen (PSA) Test Kits; Human Epidermal Growth Factor Receptor 2 (HER2) Test Kits; CA-125 Test Kits; Alpha-Fetoprotein (AFP) Test Kits; Other Cancer Marker Test Kits
6) By Urinalysis Testing Kits: Protein Testing Kits; Glucose Testing Kits; pH Testing Kits; Specific Gravity Testing Kits; Nitrite Testing Kits; Other Urinalysis Testing Kits
7) By Hematology Testing Kits: Complete Blood Count (CBC) Kits; Hemoglobin Testing Kits; Hematocrit Testing Kits; Platelet Count Kits; Other Hematology Testing Kits
8) By Drugs of Abuse Testing Kits: Marijuana Testing Kits; Cocaine Testing Kits; Opioid Testing Kits; Amphetamine Testing Kits; Other Drugs of Abuse Testing Kits
9) By Fecal Occult Testing Kits: Stool Blood Test Kits; Occult Blood Screening Kits; Other Fecal Occult Testing Kits
10) By Other Types: Glucose Monitoring Kits; Temperature Monitoring Kits; Oxygen Saturation Monitoring Kits; Other Specialty Point-of-Care Kits.
Companies Mentioned: Abbott Laboratories; F. Hoffmann-La Roche AG; Siemens Healthineers; Danaher; Beckman Coulter; Becton Dickinson and Company; Qiagen N.V.; Johnson & Johnson; Alere; BioMerieux; Chembio Diagnostic Systems; Quidel Corporation; EKF Diagnostics; Trinity Biotech Plc; OraSure Technologies; Sysmex Corporation; Radiometer Medical ApS; Response Biomedical Corporation; Bio-Rad Laboratories; Illumina; Thermo Fisher Scientific Inc.; LabCorp; Luminex Corporation; LifeScan; Nova; Sekisui Diagnostics; Hemocue AB; Akers Biosciences;
Countries: China; India; Japan; Australia; Indonesia; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; Taiwan; New Zealand; UK; Germany; France; Italy; Spain; Austria; Belgium; Denmark; Finland; Ireland; Netherlands; Norway; Portugal; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Point-of-Care Diagnostics Devices and Equipment market report include:- Abbott Laboratories
- F. Hoffmann-La Roche AG
- Siemens Healthineers
- Danaher
- Beckman Coulter
- Becton Dickinson and Company
- Qiagen N.V.
- Johnson & Johnson
- Alere
- BioMerieux
- Chembio Diagnostic Systems
- Quidel Corporation
- EKF Diagnostics
- Trinity Biotech Plc
- OraSure Technologies
- Sysmex Corporation
- Radiometer Medical ApS
- Response Biomedical Corporation
- Bio-Rad Laboratories
- Illumina
- Thermo Fisher Scientific Inc.
- LabCorp
- Luminex Corporation
- LifeScan
- Nova
- Sekisui Diagnostics
- Hemocue AB
- Akers Biosciences
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 71.62 Billion |
| Forecasted Market Value ( USD | $ 118.72 Billion |
| Compound Annual Growth Rate | 13.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 28 |
